Fear can take over the moment prostate cancer progresses. These questions can help caregivers replace confusion with clarity, ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...

The aim of this study was to explore healthcare professionals’ (HCPs) experiences of oncology consultations in which a change of treatment is proposed and discussed with patients (and their family ...

Trodelvy dosing is 10 mg/kg IV on days 1 and 8 of 21-day cycles, continued until progression or unacceptable toxicity; pembrolizumab schedules follow prescriber determination. Safety requires ...

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...

Ageing is an important risk factor for cancer incidence and augments cancer progression. A shared hallmark of ageing and cancer is metabolic reprogramming, which has been suggested to be not only a ...

A large analysis of two major clinical trials has found that the spread of prostate cancer can be detected on imaging scans even when biomarkers remain stable in patients treated with androgen ...

Metabo-oncology is an emerging interdisciplinary field at the intersection of oncology, metabolism, and obesity research. Epidemiological studies have ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have identified a molecule on the surface of cells that could be a promising therapeutic target against cancer.

Learn about new research that suggests there is a link between GLP-1 agonists and reduced breast cancer risk.

Dr Ruquaya Ahmad Mir explains why kidney cancer is often detected late. Here is why knowing the early signs is crucial.